Eva Katharina Egger Damian J Ralser Kira Lindner Florian Recker Milka Marinova Oleksandre Savchenko Jan-Frederic Lau Alexander Mustea
10.3389/fimmu.2021.686879
Front Immunol
2021 Jul 23;12:686879.
abscopal effect immune checkpoint blockade mutational burden trastuzumab vaginal adenocarcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/34367146/
Adenocarcinoma / drug therapy Adenocarcinoma of Lung / drug therapy Antineoplastic Combined Chemotherapy Protocols / therapeutic use Vaginal Neoplasms / drug therapy
Adenocarcinoma / drug therapy Adenocarcinoma of Lung / drug therapy Antineoplastic Combined Chemotherapy Protocols / therapeutic use Vaginal Neoplasms / drug therapy Case Reports Adenocarcinoma / genetics Adenocarcinoma / secondary Adenocarcinoma of Lung / genetics Adenocarcinoma of Lung / pathology Antibodies, Monoclonal, Humanized / administration & dosage Bevacizumab / administration & dosage Cisplatin / administration & dosage DNA-Binding Proteins / genetics Female Humans Immunotherapy Middle Aged Mutation Paclitaxel / administration & dosage Receptor, ErbB-2 / metabolism Transcription Factors / genetics Vaginal Neoplasms / genetics Vaginal Neoplasms / secondary ARID1A protein, human Antibodies, Monoclonal, Humanized DNA-Binding Proteins Transcription Factors Bevacizumab pembrolizumab Receptor, ErbB-2 Paclitaxel Cisplatin
PMC8342998
34367146
Diagnostic and Therapeutic Approach in a Metastatic Vaginal Adenocarcinoma: A Case Report
2021